胰岛素注射器市场规模、份额和成长分析（按註射器规格、疾病类型、最终用途、分销管道和地区划分）－2026-2033年产业预测

预计到 2024 年，全球胰岛素注射器市场规模将达到 17.7 亿美元，到 2025 年将达到 18.5 亿美元，到 2033 年将达到 25.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 4.2%。

2型糖尿病盛行率的不断上升，主要受久坐不动的生活方式、不健康的饮食习惯、都市化以及已开发国家和新兴国家肥胖率上升等因素的影响，显着推动了全球胰岛素注射器市场的发展。数以百万计的人依赖胰岛素治疗，因此对高效且经济的给药系统（例如注射器）的需求日益增长，尤其是在医疗资源匮乏、难以获得先进医疗设备的地区。同时，大型製药公司正逐步放弃传统的给药方式（例如胰岛素笔），转而研发利润更高的新型治疗方法，这导致中低收入地区患者的经济选择减少。因此，这些地区又开始重新使用传统的胰岛素注射器，加剧了那些难以采用先进技术的医疗系统对传统注射器的需求。

全球胰岛素注射器市场驱动因素

随着全球人口老化，老年人罹患糖尿病的风险日益增加，导致胰岛素需求量上升。随着糖尿病盛行率老龄化增加，胰岛素注射器的需求也持续稳定成长。这种需求的增长源于精准、规律的胰岛素注射对于有效控製糖尿病至关重要。因此，由于需要满足日益增加的胰岛素治疗患者的需求，胰岛素注射器市场正经历显着成长。人口老化与糖尿病管理之间的相互作用直接影响着市场动态，从而催生了对胰岛素输注装置的强劲需求。

全球胰岛素注射器市场限制因素

全球胰岛素注射器市场面临的一大挑战是，许多患者因为害怕针头和注射带来的不适感而不愿开始或继续胰岛素治疗。这种担忧导致患者使用注射器的动机降低，从而对患者的治疗依从性产生负面影响。因此，低遵从率阻碍了整个市场的成长和扩张，因为有效的糖尿病管理高度依赖规律的胰岛素注射。解决这些心理和生理障碍对于提高患者的接受度以及增强胰岛素输注装置的市场地位至关重要。

全球胰岛素注射器市场趋势

全球胰岛素注射器市场正呈现出显着的小型化趋势，尤其对0.5毫升小型注射器的需求日益增长。这项变化的主要驱动力是儿童患者和第1型糖尿病患者数量的增加，他们对剂量精准性和舒适度特别重视。为了满足这些需求，製造商致力于研发更紧凑、更易用的注射器，从而提高患者的依从性和整体健康管理水平。这一趋势不仅反映了患者偏好的转变，也标誌着透过创新设计方案改善糖尿病护理的更广泛努力。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术分析

全球胰岛素注射器市场规模（依注射器规格划分）及复合年增长率（2026-2033 年）

• 3/10 毫升注射器（0.3 毫升）
• 1/2 毫升注射器（0.5 毫升）
• 1毫升注射器
• 其他的

全球胰岛素注射器市场规模（按疾病类型和复合年增长率划分）（2026-2033 年）

• 1型糖尿病
• 2型糖尿病

全球胰岛素注射器市场规模（依最终用途划分）及复合年增长率（2026-2033 年）

• 医院和诊所
• 居家医疗环境
• 其他的

全球胰岛素注射器市场规模（按分销管道划分）及复合年增长率（2026-2033 年）

• 医院药房
• 零售药房
• 网路药房

全球胰岛素注射器市场规模（以针头长度划分）及复合年增长率（2026-2033 年）

• 短的
• 中等的
• 长的

全球胰岛素注射器市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 标准胰岛素注射器
• 安全胰岛素注射器

全球胰岛素注射器市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Novo Nordisk A/S（Denmark）
• Eli Lilly and Company（US）
• Sanofi SA（France）
• Becton, Dickinson and Company（BD）（US）
• Terumo Corporation（Japan）
• Cardinal Health Inc.（US）
• Medtronic plc（Ireland）
• Abbott Laboratories（US）
• Nipro Corporation（Japan）
• Biocon Ltd.（India）
• Hindustan Syringes & Medical Devices Ltd.（India）
• B. Braun Melsungen AG（Germany）
• Ypsomed Holding AG（Switzerland）
• Stevanato Group SpA（Italy）
• Schott Pharma AG & Co. KGaA（Germany）
• ApiJect Systems Corporation（US）
• Teleflex Incorporated（US）
• Owen Mumford Ltd.（UK）
• Allison Medical Inc.（US）

结论与建议

Global Insulin Syringes Market size was valued at USD 1.77 Billion in 2024 and is poised to grow from USD 1.85 Billion in 2025 to USD 2.57 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The escalating incidence of diabetes, predominantly type 2, significantly propels the global insulin syringes market, fueled by factors like sedentary lifestyles, unhealthy eating habits, urbanization, and rising obesity levels in both advanced and emerging economies. With millions reliant on insulin therapy, the demand for efficient and cost-effective delivery systems, such as syringes, is intensifying, especially in resource-limited settings where more advanced devices are inaccessible. Concurrently, major pharmaceutical companies are transitioning from older insulin delivery methods, like human insulin pens, to newer, high-margin treatments, ultimately reducing affordable options for patients in low- to middle-income regions. As a result, these populations are increasingly reverting to conventional insulin syringes, impacting demand positively within healthcare systems that lack support for more advanced technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Syringes Market Segments Analysis

Global Insulin Syringes Market is segmented by Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type and region. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1 CC Syringe (1ml) and Others. Based on Disease Type, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on End-Use, the market is segmented into Hospitals & Clinics, Homecare Settings and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on Needle Length, the market is segmented into Short, Medium and Long. Based on Product Type, the market is segmented into Standard Insulin Syringes and Safety Insulin Syringes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Syringes Market

The expanding global elderly population faces a heightened risk of diabetes, leading to an increased requirement for insulin. As the prevalence of age-related diabetes rises, the demand for insulin syringes continues to grow steadily. This surge is driven by the critical need for accurate and regular insulin injections to manage the condition effectively. Consequently, the market for insulin syringes experiences significant growth, fueled by the ongoing necessity to accommodate the escalating number of individuals requiring insulin therapy. The interplay between an aging demographic and diabetes management directly influences market dynamics, resulting in a robust demand for insulin administration devices.

Restraints in the Global Insulin Syringes Market

A significant challenge facing the global insulin syringes market is the reluctance of many patients to initiate or maintain insulin therapy due to fear of needles and the discomfort associated with injections. This apprehension leads to a decreased willingness to use syringes consistently, which adversely affects patient adherence to treatment regimens. Consequently, low compliance rates hinder the overall growth and expansion of the market, as effective diabetes management relies heavily on regular insulin administration. Addressing these psychological and physical barriers is crucial for improving patient acceptance and fostering a more robust market presence for insulin delivery devices.

Market Trends of the Global Insulin Syringes Market

The Global Insulin Syringes market is witnessing a significant trend towards miniaturization, with a growing demand for smaller insulin syringes, particularly those holding 0.5 ml. This shift is primarily driven by an increasing population of pediatric patients and individuals with Type 1 diabetes, who prioritize dosing accuracy and comfort. As manufacturers respond to these needs, the development of more compact and user-friendly syringes has emerged as a critical focus, enhancing patient compliance and overall health management. This trend not only reflects the evolving preferences of patients but also a broader commitment to improving diabetes care through innovative design solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis

Global Insulin Syringes Market Size by Syringe Size & CAGR (2026-2033)

• Market Overview
• 3/10 CC Syringe (0.3ml)
• 1/2 CC Syringe (0.5ml)
• 1 CC Syringe (1ml)
• Others

Global Insulin Syringes Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Insulin Syringes Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Homecare Settings
• Others

Global Insulin Syringes Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Insulin Syringes Market Size by Needle Length & CAGR (2026-2033)

• Market Overview
• Short
• Medium
• Long

Global Insulin Syringes Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Standard Insulin Syringes
• Safety Insulin Syringes

Global Insulin Syringes Market Size & CAGR (2026-2033)

• North America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • US
  • Canada
• Europe (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hindustan Syringes & Medical Devices Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott Pharma AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ApiJect Systems Corporation (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allison Medical Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations